
Akhil Santhosh
Jan 25, 2025, 03:14
Akhil Santhosh: Carboplatin, Paclitaxel, and Atezolizumab in the Treatment of Thymic Cancer
Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post on X:
“MARBLE study: single arm phase 2 study of carbo+ pacli+ atezo in thymic cancer (n=48)
ORR 56.3%, DCR 97.2%
1 year PFS 43.3%, 1 Year OS 91.3%
all patients had any grade IRAE, 66.7% grade 3.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 6, 2025, 12:54
Mar 6, 2025, 12:37
Mar 6, 2025, 12:21
Mar 6, 2025, 10:44
Mar 6, 2025, 10:40
Mar 6, 2025, 10:30